phenobarbital has been researched along with Endotoxemia in 1 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minamiyama, Y | 1 |
| Takemura, S | 1 |
| Toyokuni, S | 1 |
| Imaoka, S | 1 |
| Funae, Y | 1 |
| Hirohashi, K | 1 |
| Yoshikawa, T | 1 |
| Okada, S | 1 |
1 other study available for phenobarbital and Endotoxemia
| Article | Year |
|---|---|
CYP3A induction aggravates endotoxemic liver injury via reactive oxygen species in male rats.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Endotoxemia; Enzyme Induction; Lipop | 2004 |